Transcutaneous Electric Nerve Stimulation Effect in Parkinson's Disease
- Conditions
- Pain in Parkinson's DiseaseC10.597.617F02.3C10.228.140.079.862.500
- Registration Number
- RBR-4bvwxq
- Lead Sponsor
- niversidade Federal de Sergipe
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- Not specified
Inclusion criteria comprehend:subjects of both sexes and aged between 50 and 80 years; presence of motor fluctuations; conventional antiparkinsonian therapy excluding amantadine , clozapine, deep brain stimulation or pallidotomy and previous thalamotomy; ability to remain standing for at least 10 minutes; ability to walk independently with or without assistive devices; complaint of pain in the spine, with the presence or absence of irradiation to limbs and characterized as neuropathic (continuous and diffuse spontaneous pain, sensory loss, allodynia and hyperalgesia). Targer sample 80 patients.
Subjects will be excluded if: the medical or physical examination scores below 24 on the Mini Mental State Examination; there are systemic conditions, such as heart disease, that would interfere with the participation in the study; there is musculoskeletal damage or excessive pain in any joint that may limit participation in an exercise program; there is psychiatric disorder, cognitive decline or dementia influencing the communication process; there is musculoskeletal, cardiopulmonary or neuromuscular disorder ,recent or unresolved, which may affect their ability to walk or mobility; they are under physiotherapeutic treatment during the period of training; there is presence of contraindications for use of TENS, such as ulcerations or allergy to the material; there was previous use of TENS; there is chronic use of opioids or antidepressants; there is use of a cardiac pacemaker; there is reduced sensitivity at sites where the electrodes will be placed; there was previous back surgery.
Study & Design
- Study Type
- Intervention
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method